| HOME >> BIOLOGY >> TECHNOLOGY |
NEW YORK, November 20 /PRNewswire-FirstCall/ -- SPO Medical Inc. (OTC: SPOM - News), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, announced its results for the nine-month period ended September 30, 2008.
Despite the continued deterioration in the macro-economic environment, gross revenues for the nine month period were US$2,421,000; declines in sales were mainly due to the lower sales in the US homecare market, which have been adversely affected by the current financial crisis. Sales of medical product have grown in areas outside the US, specifically in the Asian-Pacific marketplace.
During the third quarter of 2008, the Company continued to focus efforts in the medical market with its PulseOx 6000(TM) and PulseOx 6100(TM) lines for professional healthcare establishments and are currently involved in several tenders with these products. Additional commercial ventures are being sought via private labeling opportunities of the medical PulseOx product line. The Company believes that that this strategy will help realign revenue potentials.
Most recently, the Company has achieved significant technological progress with its non-medical market opportunities specifically with the baby monitor product line. We have developed a unique substrate for mounting the optical sensors and associated electronic components, which are combined to form a practical and durable baby ankle bracelet. This critical component will be entering limited field trials so that the baby monitor can commence further comprehensive market testing during 2009. The Company has plans to extend its non-medical product offering to include additional consumer mass-market applications using its proprietary reflective pulse-oximetry technology and is currently in discussion with several international organizations for marketing cooperation's in this regard.
Michael Braun
'/>"/>
| SOURCE SPO Medical Inc Copyright©2008 PR Newswire. All rights reserved |